Despite trading near their 52-week highs, AU Small Finance Bank, Lloyds Metals, Sona BLW, and Alkem Laboratories show strong earnings growth. Investors are evaluating whether these companies offer value or if their high valuations are becoming a concern as profits rise.
Investors often avoid stocks trading near their 52-week highs, fearing that the best gains have already passed. However, financial markets sometimes present a different story where earnings grow faster than share prices. When a company’s profit increases significantly, its valuation multiples—such as the price-to-earnings (P/E) ratio—can actually contract, making the stock more attractive despite a higher price tag. Four midcap companies currently demonstrate this trend, though each comes with its own set of business risks.
AU Small Finance Bank
AU Small Finance Bank has grown from a vehicle-finance focused lender into a full-service small finance bank. The stock is currently trading near ₹1,068, remaining close to its 52-week high of ₹1,105.90. The bank reported a net profit of ₹2,640 crore for FY26, a rise of 25.4%. While the stock trades at a valuation premium compared to the broader banking sector, many analysts focus on its strong historical performance. Investors tracking this stock should watch for loan book growth and the ability of the bank to manage risks in its lending segments.
Lloyds Metals & Energy
Lloyds Metals & Energy has captured market attention with a 603% year-on-year jump in net profit during the March 2026 quarter. As an integrated iron ore miner and steel producer with a mining capacity of 10 million tonnes per year, the company has benefited from recent expansions. The stock trades near the ₹2,100 level. However, the steel industry is highly cyclical, meaning that commodity price swings can significantly impact profitability. Potential investors often monitor the company’s ability to maintain high production levels and manage the risks associated with raw material price volatility.
Sona BLW Precision Forgings
Sona BLW Precision Forgings has seen strong momentum, hitting a fresh 52-week high of ₹836.80 on August 10, 2026. The company is a key player in the electric vehicle (EV) supply chain, providing critical drivetrain components. Its growth strategy is heavily tied to the global shift toward EVs, with management aiming for a significant portion of revenue to come from this segment. While the company's research and product expansion have received positive feedback from analysts, shareholders keep a close eye on the volatile nature of the auto-component sector and global demand trends.
Alkem Laboratories
Alkem Laboratories, a major player in the Indian generics market, is currently trading near ₹5,620. The company is approaching a busy period with two key dates on the horizon. It has scheduled an Extraordinary General Meeting (EGM) for August 17, 2026, to vote on the amalgamation of its subsidiary, Adroit Biomed. Additionally, the company is set to release its quarterly results on August 14, 2026. While the company has a strong footprint, investors remain cautious about ongoing regulatory inspections, such as the USFDA activity at its Taloja facility, which can influence market sentiment.
For these companies, the next phase of growth will depend on whether they can maintain their current profit margins and successfully execute their planned expansions. Investors tracking these stocks may look for further clarity on sector-specific demand, regulatory updates, and the upcoming financial disclosures.